Effectiveness and Safety of DOACs vs. VKAs in AF Patients With Cancer: Evidence From Randomized Clinical Trials and Observational Studies

Background: The use of direct oral anticoagulants (DOACs) is recommended as the preferred treatment drug in patients with nonvalvular atrial fibrillation (AF). However, the effectiveness and safety of DOACs compared with vitamin K antagonists (VKAs) in patients with cancer and AF are still controver...

Full description

Saved in:
Bibliographic Details
Main Authors: Fuwei Liu, Zixuan Xu, Jun Luo, Peng Yu, Jianyong Ma, Ping Yuan, Wengen Zhu
Format: article
Language:EN
Published: Frontiers Media S.A. 2021
Subjects:
Online Access:https://doaj.org/article/b324455df1fc4310aac2e7289142aeda
Tags: Add Tag
No Tags, Be the first to tag this record!